- call +1-201-465-4211
- email sales@mrinsights.biz
Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial therapeutic agents that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside (sugar); the term can also refer more generally to any organic molecule that contains aminosugar substructures. Aminoglycoside antibiotics display bactericidal activity against Gram-negative aerobes and some anaerobic bacilli where resistance has not yet arisen but generally not against Gram-positive and anaerobic Gram-negative bacteria.
Scope of the Report:
This report focuses on the Aminoglycosides in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Asia Pacific accounted for the largest share of revenue in 2014 that is due to higher incidence rate of multi-drug resistant tuberculosis that needs second line drugs for treatment is attributive towards a larger considerably larger share of kanamycin and capreomycin in the Asia Pacific region along with the significant availability of other aminoglycosides as well.
The worldwide market for Aminoglycosides is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Kremoint Pharma Pvt. Ltd
Vega Pharma Ltd.
Jiangxi Bolai Pharmacy Co., Ltd.
Xian Wison Biological Technology Co., Ltd.
Hangzhou Uniwise International Co., Ltd.
HuvePharma
Yi Chang Veterinary Medicine Factory
Medson Pharmaceuticals
Medico Remedies Pvt. Ltd.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Neomycin
Tobramycin
Gentamicin
Amikacin
Paromomycin
Streptomycin
Kanamycin
Others
Market Segment by Applications, can be divided into
Veterinary
Skin Infection
Respiratory Diseases
UTI & Pelvic Diseases
Other Diseases
There are 15 Chapters to deeply display the global Aminoglycosides market.
Chapter 1, to describe Aminoglycosides Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Aminoglycosides, with sales, revenue, and price of Aminoglycosides, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Aminoglycosides, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Aminoglycosides market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Aminoglycosides sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Aminoglycosides Introduction
1.2 Market Analysis by Type
1.2.1 Neomycin
1.2.2 Tobramycin
1.2.3 Gentamicin
1.2.4 Amikacin
1.2.5 Paromomycin
1.2.6 Streptomycin
1.2.7 Kanamycin
1.2.8 Others
1.3 Market Analysis by Applications
1.3.1 Veterinary
1.3.2 Skin Infection
1.3.3 Respiratory Diseases
1.3.4 UTI & Pelvic Diseases
1.3.5 Other Diseases
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Kremoint Pharma Pvt. Ltd
2.1.1 Business Overview
2.1.2 Aminoglycosides Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Kremoint Pharma Pvt. Ltd Aminoglycosides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Vega Pharma Ltd.
2.2.1 Business Overview
2.2.2 Aminoglycosides Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Vega Pharma Ltd. Aminoglycosides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Jiangxi Bolai Pharmacy Co., Ltd.
2.3.1 Business Overview
2.3.2 Aminoglycosides Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Jiangxi Bolai Pharmacy Co., Ltd. Aminoglycosides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Xian Wison Biological Technology Co., Ltd.
2.4.1 Business Overview
2.4.2 Aminoglycosides Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Xian Wison Biological Technology Co., Ltd. Aminoglycosides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Hangzhou Uniwise International Co., Ltd.
2.5.1 Business Overview
2.5.2 Aminoglycosides Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Hangzhou Uniwise International Co., Ltd. Aminoglycosides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 HuvePharma
2.6.1 Business Overview
2.6.2 Aminoglycosides Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 HuvePharma Aminoglycosides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Yi Chang Veterinary Medicine Factory
2.7.1 Business Overview
2.7.2 Aminoglycosides Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Yi Chang Veterinary Medicine Factory Aminoglycosides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Medson Pharmaceuticals
2.8.1 Business Overview
2.8.2 Aminoglycosides Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Medson Pharmaceuticals Aminoglycosides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Medico Remedies Pvt. Ltd.
2.9.1 Business Overview
2.9.2 Aminoglycosides Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Medico Remedies Pvt. Ltd. Aminoglycosides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Aminoglycosides Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Aminoglycosides Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Aminoglycosides Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Aminoglycosides Manufacturer Market Share in 2017
3.3.2 Top 6 Aminoglycosides Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Aminoglycosides Market Analysis by Regions
4.1 Global Aminoglycosides Sales, Revenue and Market Share by Regions
4.1.1 Global Aminoglycosides Sales and Market Share by Regions (2013-2018)
4.1.2 Global Aminoglycosides Revenue and Market Share by Regions (2013-2018)
4.2 North America Aminoglycosides Sales and Growth Rate (2013-2018)
4.3 Europe Aminoglycosides Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Aminoglycosides Sales and Growth Rate (2013-2018)
4.5 South America Aminoglycosides Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Aminoglycosides Sales and Growth Rate (2013-2018)
5 North America Aminoglycosides by Countries
5.1 North America Aminoglycosides Sales, Revenue and Market Share by Countries
5.1.1 North America Aminoglycosides Sales and Market Share by Countries (2013-2018)
5.1.2 North America Aminoglycosides Revenue and Market Share by Countries (2013-2018)
5.2 United States Aminoglycosides Sales and Growth Rate (2013-2018)
5.3 Canada Aminoglycosides Sales and Growth Rate (2013-2018)
5.4 Mexico Aminoglycosides Sales and Growth Rate (2013-2018)
6 Europe Aminoglycosides by Countries
6.1 Europe Aminoglycosides Sales, Revenue and Market Share by Countries
6.1.1 Europe Aminoglycosides Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Aminoglycosides Revenue and Market Share by Countries (2013-2018)
6.2 Germany Aminoglycosides Sales and Growth Rate (2013-2018)
6.3 UK Aminoglycosides Sales and Growth Rate (2013-2018)
6.4 France Aminoglycosides Sales and Growth Rate (2013-2018)
6.5 Russia Aminoglycosides Sales and Growth Rate (2013-2018)
6.6 Italy Aminoglycosides Sales and Growth Rate (2013-2018)
7 Asia-Pacific Aminoglycosides by Countries
7.1 Asia-Pacific Aminoglycosides Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Aminoglycosides Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Aminoglycosides Revenue and Market Share by Countries (2013-2018)
7.2 China Aminoglycosides Sales and Growth Rate (2013-2018)
7.3 Japan Aminoglycosides Sales and Growth Rate (2013-2018)
7.4 Korea Aminoglycosides Sales and Growth Rate (2013-2018)
7.5 India Aminoglycosides Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Aminoglycosides Sales and Growth Rate (2013-2018)
8 South America Aminoglycosides by Countries
8.1 South America Aminoglycosides Sales, Revenue and Market Share by Countries
8.1.1 South America Aminoglycosides Sales and Market Share by Countries (2013-2018)
8.1.2 South America Aminoglycosides Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Aminoglycosides Sales and Growth Rate (2013-2018)
8.3 Argentina Aminoglycosides Sales and Growth Rate (2013-2018)
8.4 Colombia Aminoglycosides Sales and Growth Rate (2013-2018)
9 Middle East and Africa Aminoglycosides by Countries
9.1 Middle East and Africa Aminoglycosides Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Aminoglycosides Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Aminoglycosides Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Aminoglycosides Sales and Growth Rate (2013-2018)
9.3 UAE Aminoglycosides Sales and Growth Rate (2013-2018)
9.4 Egypt Aminoglycosides Sales and Growth Rate (2013-2018)
9.5 Nigeria Aminoglycosides Sales and Growth Rate (2013-2018)
9.6 South Africa Aminoglycosides Sales and Growth Rate (2013-2018)
10 Global Aminoglycosides Market Segment by Type
10.1 Global Aminoglycosides Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Aminoglycosides Sales and Market Share by Type (2013-2018)
10.1.2 Global Aminoglycosides Revenue and Market Share by Type (2013-2018)
10.2 Neomycin Sales Growth and Price
10.2.1 Global Neomycin Sales Growth (2013-2018)
10.2.2 Global Neomycin Price (2013-2018)
10.3 Tobramycin Sales Growth and Price
10.3.1 Global Tobramycin Sales Growth (2013-2018)
10.3.2 Global Tobramycin Price (2013-2018)
10.4 Gentamicin Sales Growth and Price
10.4.1 Global Gentamicin Sales Growth (2013-2018)
10.4.2 Global Gentamicin Price (2013-2018)
10.5 Amikacin Sales Growth and Price
10.5.1 Global Amikacin Sales Growth (2013-2018)
10.5.2 Global Amikacin Price (2013-2018)
10.6 Paromomycin Sales Growth and Price
10.6.1 Global Paromomycin Sales Growth (2013-2018)
10.6.2 Global Paromomycin Price (2013-2018)
10.7 Streptomycin Sales Growth and Price
10.7.1 Global Streptomycin Sales Growth (2013-2018)
10.7.2 Global Streptomycin Price (2013-2018)
10.8 Kanamycin Sales Growth and Price
10.8.1 Global Kanamycin Sales Growth (2013-2018)
10.8.2 Global Kanamycin Price (2013-2018)
10.9 Others Sales Growth and Price
10.9.1 Global Others Sales Growth (2013-2018)
10.9.2 Global Others Price (2013-2018)
11 Global Aminoglycosides Market Segment by Application
11.1 Global Aminoglycosides Sales Market Share by Application (2013-2018)
11.2 Veterinary Sales Growth (2013-2018)
11.3 Skin Infection Sales Growth (2013-2018)
11.4 Respiratory Diseases Sales Growth (2013-2018)
11.5 UTI & Pelvic Diseases Sales Growth (2013-2018)
11.6 Other Diseases Sales Growth (2013-2018)
12 Aminoglycosides Market Forecast (2018-2023)
12.1 Global Aminoglycosides Sales, Revenue and Growth Rate (2018-2023)
12.2 Aminoglycosides Market Forecast by Regions (2018-2023)
12.2.1 North America Aminoglycosides Market Forecast (2018-2023)
12.2.2 Europe Aminoglycosides Market Forecast (2018-2023)
12.2.3 Asia-Pacific Aminoglycosides Market Forecast (2018-2023)
12.2.4 South America Aminoglycosides Market Forecast (2018-2023)
12.2.5 Middle East and Africa Aminoglycosides Market Forecast (2018-2023)
12.3 Aminoglycosides Market Forecast by Type (2018-2023)
12.3.1 Global Aminoglycosides Sales Forecast by Type (2018-2023)
12.3.2 Global Aminoglycosides Market Share Forecast by Type (2018-2023)
12.4 Aminoglycosides Market Forecast by Application (2018-2023)
12.4.1 Global Aminoglycosides Sales Forecast by Application (2018-2023)
12.4.2 Global Aminoglycosides Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Aminoglycosides Picture
Table Product Specifications of Aminoglycosides
Figure Global Sales Market Share of Aminoglycosides by Types in 2017
Table Amino
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
